Details for New Drug Application (NDA): 206886
✉ Email this page to a colleague
The generic ingredient in AFIRMELLE is ethinyl estradiol; levonorgestrel. There are twenty-six drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; levonorgestrel profile page.
Summary for 206886
Tradename: | AFIRMELLE |
Applicant: | Aurobindo Pharma |
Ingredient: | ethinyl estradiol; levonorgestrel |
Patents: | 0 |
Suppliers and Packaging for NDA: 206886
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
AFIRMELLE | ethinyl estradiol; levonorgestrel | TABLET;ORAL-28 | 206886 | ANDA | Afaxys Pharma, LLC | 50102-220 | 50102-220-23 | 3 POUCH in 1 CARTON (50102-220-23) / 1 BLISTER PACK in 1 POUCH (50102-220-21) / 1 KIT in 1 BLISTER PACK |
AFIRMELLE | ethinyl estradiol; levonorgestrel | TABLET;ORAL-28 | 206886 | ANDA | RPK Pharmaceuticals, Inc. | 53002-2692 | 53002-2692-1 | 1 BLISTER PACK in 1 PACKAGE (53002-2692-1) / 1 KIT in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL-28 | Strength | 0.02MG;0.1MG | ||||
Approval Date: | Nov 14, 2016 | TE: | AB1 | RLD: | No |
Complete Access Available with Subscription